Peptide Therapeutics Market 2025 to 2034
Peptide Therapeutics Market 2025 to 2034
Peptide Therapeutics Market (By Application: Gastrointestinal Disorder, Metabolic Disorder, Neurological Disorder, Cancer, Others; By Type: Generic, Innovative; By Route of Administration: Oral, Parenteral, Pulmonary, Mucosal, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Drug Stores; By Synthesis Technology: Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034.
Customisation Request
Revenue, 2025
USD 52.59 Bn
Forecast Year, 2035
USD 87.21 Bn
CAGR, 2025 - 2035
5.19%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global peptide therapeutics market is valued at USD 52.59 billion in 2025 and is projected to reach USD 87.21 billion by 2034, growing at a CAGR of 5.19%, driven by rising demand for targeted therapies and novel peptide-based drugs.
Peptide Therapeutics Market Size Analysis
Peptide Therapeutics Market Size By Application 2025 to 2035 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gastrointestinal Disorder | 10.43 | 10.27 | 9.99 | 9.99 | 10.97 | 12.04 | 12.35 | 13.38 | 13.18 | 14.85 | 15.74 |
| Metabolic Disorder | 12.27 | 13.59 | 14.45 | 15.57 | 16.88 | 18.60 | 18.36 | 18.98 | 20.97 | 21.57 | 22.79 |
| Neurological Disorder | 8.17 | 8.64 | 9.48 | 10.05 | 9.86 | 10.26 | 11.01 | 11.17 | 12.78 | 12.37 | 14.12 |
| Cancer | 16.31 | 16.40 | 17.01 | 17.88 | 18.56 | 19.14 | 20.61 | 21.04 | 21.61 | 22.57 | 22.69 |
| Others | 5.41 | 6.41 | 7.25 | 7.71 | 8.12 | 7.70 | 8.91 | 10.37 | 10.28 | 11.56 | 11.88 |
Peptide Therapeutics Market Size By Type 2025 to 2035 (USD Billion)
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Generic | 19.07 | 20.52 | 22.16 | 23.51 | 24.24 | 25.48 | 26.21 | 27.64 | 28.46 | 30.37 | 32.37 |
| Innovative | 33.52 | 34.80 | 36.03 | 37.70 | 40.15 | 42.25 | 45.03 | 47.30 | 50.37 | 52.55 | 54.86 |
Peptide Therapeutics Market Size By Route of Administration 2025 to 2035 (USD Billion)
| Route of Administration | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 15.26 | 15.40 | 15.68 | 16.37 | 17.26 | 18.74 | 20.42 | 21.09 | 20.84 | 21.68 | 22.87 |
| Parenteral | 18.45 | 19.80 | 20.89 | 21.73 | 22.52 | 23.42 | 24.96 | 25.56 | 27.27 | 28.65 | 30.22 |
| Pulmonary | 10.61 | 11.00 | 11.25 | 12.21 | 12.97 | 13.26 | 13.30 | 14.17 | 14.04 | 13.82 | 13.76 |
| Mucosal | 19.07 | 20.52 | 22.16 | 23.51 | 24.24 | 25.48 | 26.21 | 27.64 | 28.46 | 30.37 | 32.37 |
| Others | 2.26 | 1.66 | 1.83 | 1.81 | 2.25 | 3.25 | 3.78 | 3.61 | 4.90 | 4.48 | 4.17 |
Peptide Therapeutics Market Size By Distribution Channel 2025 to 2035 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 23.40 | 24.26 | 25.64 | 27.52 | 29.28 | 31.73 | 33.50 | 35.46 | 37.94 | 40.05 | 42.81 |
| Retail Pharmacies | 18.45 | 19.80 | 20.89 | 21.73 | 22.52 | 23.42 | 24.96 | 25.56 | 27.27 | 28.65 | 30.22 |
| Online Drug Stores | 10.75 | 11.26 | 11.66 | 11.96 | 12.59 | 12.58 | 12.78 | 13.92 | 13.63 | 14.22 | 14.19 |
Peptide Therapeutics Market Size By Synthesis Technology 2025 to 2035 (USD Billion)
| Synthesis Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Solid Phase Peptide Synthesis (SPPS) | 26.82 | 28.94 | 30.76 | 31.56 | 32.79 | 33.96 | 36.53 | 38.61 | 41.49 | 44.03 | 46.38 |
| Liquid Phase Peptide Synthesis (LPPS) | 15.17 | 15.38 | 16.19 | 17.44 | 18.62 | 20.50 | 21.42 | 22.16 | 23.31 | 25.07 | 27.09 |
| Hybrid Technology | 10.61 | 11.00 | 11.25 | 12.21 | 12.97 | 13.26 | 13.30 | 14.17 | 14.04 | 13.82 | 13.76 |
Peptide Therapeutics Market Size By Region 2025 to 2035 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 18.67 | 19.50 | 19.84 | 21.55 | 22.70 | 24.42 | 25.29 | 25.69 | 27.45 | 29.18 | 29.98 |
| Europe | 33.52 | 34.80 | 36.03 | 37.70 | 40.15 | 42.25 | 45.03 | 47.30 | 50.37 | 52.55 | 54.86 |
| Asia-Pacific | 15.17 | 15.38 | 16.19 | 17.44 | 18.62 | 20.50 | 21.42 | 22.16 | 23.31 | 25.07 | 27.09 |
| Latin America | 3.02 | 2.60 | 2.83 | 2.42 | 2.92 | 3.50 | 4.33 | 5.27 | 5.34 | 6.43 | 7.99 |
| The Middle East and Africa | 23.40 | 24.26 | 25.64 | 27.52 | 29.28 | 31.73 | 33.50 | 35.46 | 37.94 | 40.05 | 42.81 |
Peptide Therapeutics Market Size to Reach USD 87.21 Billion by 2035
The global peptide therapeutics market size was estimated at USD 52.59 billion in 2025 and is projected to be worth around USD 87.21 billion by 2034,with a CAGR of 5.19%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
